Expressions of HLA Class II Genes in Cutaneous Melanoma Were Associated with Clinical Outcome: Bioinformatics Approaches and Systematic Analysis of Public Microarray and RNA-Seq Datasets

Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas

(2019) Alessandro Mangogna et al.   Frontiers in Immunology

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of anti-PD-1 Therapies in Metastatic Melanoma

(2018) Douglas B. Johnson et al.   CLINICAL CANCER RESEARCH

OmicsNet: a web-based tool for creation and visual analysis of biological networks in 3D space

(2018) Guangyan Zhou et al.   NUCLEIC ACIDS RESEARCH

MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma

(2018) Scott J. Rodig et al.   Science Translational Medicine

Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma

(2018) Carlos R. Figueiredo et al.   Frontiers in Immunology

CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival

(2018) P. S. Zeiner et al.   Acta Neuropathologica Communications

Biological Consequences of Major Histocompatibility Class-II Expression by Tumor Cells in Cancer

(2018) Margaret L Axelrod et al.   CLINICAL CANCER RESEARCH

Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function

(2017) John van Tuyn et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling

(2017) In Ah Park et al.   PLoS One

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

(2017) Darshan S. Chandrashekar et al.   NEOPLASIA

HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance

(2017) Barbara Seliger et al.   OncoImmunology

Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma

(2016) S. Ekmekcioglu et al.   CLINICAL CANCER RESEARCH

Predictors of tumor-infiltrating lymphocyte efficacy in melanoma

(2016) Dragoslav Zikich et al.   Immunotherapy

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers

(2016) Claudia Sanna et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible

(2016) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation

(2016) Roberta Bulla et al.   Nature Communications

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

(2016) Douglas B. Johnson et al.   Nature Communications

Genomic Classification of Cutaneous Melanoma

(2015) Rehan Akbani et al.   CELL

Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ

(2015) Keiji Tanese et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

MERAV: a tool for comparing gene expression across human tissues and cell types

(2015) Yoav D. Shaul et al.   NUCLEIC ACIDS RESEARCH

The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans

(2015) et al.   SCIENCE

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

Overview of Complement Activation and Regulation

(2013) Marina Noris et al.   SEMINARS IN NEPHROLOGY

Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can)

(2012) G. Nagel et al.   BRITISH JOURNAL OF DERMATOLOGY

MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells

(2012) Cristina Garrido et al.   CARCINOGENESIS

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Identification of Cell Surface Proteins as Potential Immunotherapy Targets in 12 Pediatric Cancers

(2012) Rimas J. Orentas et al.   Frontiers in Oncology

Ectopic expression of CD74 in Ikkβ-deleted mouse hepatocytes

(2010) Katherine S. Koch et al.   ACTA HISTOCHEMICA

HLA and DR antigen frequencies in melanoma patients: possible relation to disease prognosis

(2010) Marilyn S. Pollack et al.   TISSUE ANTIGENS

Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment

(2009) H. Harlin et al.   CANCER RESEARCH

Coexpression of major histocompatibility complex class II with chemokines and nuclear NFκB p50 in melanoma: a rational for their association with poor prognosis

(2009) Isabelle Martins et al.   MELANOMA RESEARCH

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Complement C1q Activates Tumor Suppressor WWOX to Induce Apoptosis in Prostate Cancer Cells

(2009) Qunying Hong et al.   PLoS One

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

(2009) D. Bogunovic et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer

(2008) M. J. Callahan et al.   CLINICAL CANCER RESEARCH